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Background: Musculoskeletal pain is a major contributor to short and long term work absence. Patients seek care
from their general practitioner (GP) and yet GPs often feel ill-equipped to deal with work issues. Providing a vocational
case management service in primary care, to support patients with musculoskeletal problems to remain at or return to
work, is one potential solution but requires robust evaluation to test clinical and cost-effectiveness.
Methods/Design: This protocol describes a cluster randomised controlled trial, with linked qualitative interviews, to
investigate the effect of introducing a vocational advice service into general practice, to provide a structured approach
to managing work related issues in primary care patients with musculoskeletal pain who are absent from work or
struggling to remain in work. General practices (n = 6) will be randomised to offer best current care or best current care
plus a vocational advice service. Adults of working age who are absent from or struggling to remain in work due to a
musculoskeletal pain problem will be invited to participate and 330 participants will be recruited. Data collection will
be through patient completed questionnaires at baseline, 4 and 12 months. The primary outcome is self-reported work
absence at 4 months. Incremental cost-utility analysis will be undertaken to calculate the cost per additional QALY
gained and incremental net benefits. A linked interview study will explore the experiences of the vocational advice
service from the perspectives of GPs, nurse practitioners (NPs), patients and vocational advisors.
Discussion: This paper presents the rationale, design, and methods of the Study of Work And Pain (SWAP) trial. The
results of this trial will provide evidence to inform primary care practice and guide the development of services to
provide support for musculoskeletal pain patients with work-related issues.
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Musculoskeletal pain and in particular acute back pain are
major contributors to short term (less than 20 working
days) and long term (greater than 20 working days) work
absence, accounting for 38% and 37% of short-term
absence respectively in manual jobs and 37% and 28% re-
spectively in non-manual jobs [1]. However, around one
third of all work absence is attributable to long-term mus-
culoskeletal conditions accounting for long-term absence
in 37% of manual and 34% of non-manual jobs [1].
Current policy regarding health and work
The health service costs and lost capacity in the work-
place have made health and work a key target for public
policy [2]. In the UK the Government is actively aiming
to reduce the number of employees signed off sick each
year [3]. Provision of occupational health in the work-
place in the UK is currently limited. Even when occupa-
tional health services are broadly defined, only 15% of
UK employers provide such a service and these are gen-
erally the larger organisations [4]. Occupational health
services are even less likely to be provided in Small and
Medium Enterprises (SMEs), which employ an estimated
13.5 million people [4,5]. For the vast majority of SME
employees, in the UK and elsewhere, the first line of oc-
cupational health care is their primary care practitioner
and there is a strong case for primary care services being
involved in work-related health interventions by provid-
ing more options to refer patients [6].
Limitations of current occupational health care for
musculoskeletal pain
The benefits of remaining active despite pain have been
well documented in workers with musculoskeletal pain and
back pain in particular, leading to less sick leave, less time
on modified duties and a reduction in pain recurrence
[7-10]. A review of vocational rehabilitation highlighted pri-
mary care as a key arena in which to address the issue of
work with patients [11]. Although there are guidelines in
place to support primary care practitioners in providing ap-
propriate advice about work [12-17], many GPs have limited
training in work issues [18] and they often report that they
feel ill-equipped to deal with patients’ concerns about work
[19,20]. In the UK this is particularly important given the
introduction of the ‘Statement of Fitness for Work’ which re-
places the sickness certificate, requiring GPs to assess fitness
for work and provide their patients with more specific advice
regarding activities (e.g. altered hours or modified activities)
that may facilitate successful return to work.
Interventions to facilitate return to work
Initiatives addressing health and work have been pre-
dominantly policy driven, such as Job Centre Plus, the
Job Retention and Rehabilitation Pilot and the Pathwaysto Work initiatives in the UK [21,22] and are often di-
rected towards people who have extended work absence
(greater than 6 months). Yet evidence from back pain re-
search suggests that the longer an individual is out of
work, the harder it is for them to get back into work [23],
therefore it is logical to tackle absence before it becomes
long-term. Evidence suggests that intervening in the early
stages of sickness absence may be effective for many
people with musculoskeletal conditions and yet most ini-
tiatives currently are directed towards longer-term ab-
sence from work [6,9,11].
In the research arena there are a range of interventions
addressing shorter term absence that have been tested to
examine their effects on work absence, these include but
are not limited to back schools, exercise programmes, work
hardening programmes and educational programmes
[24,25]. However, these interventions have mostly been
undertaken in the workplace, and they have been tailored
to the specific needs of the organisations in which they have
taken place.
There are methods by which the impact of health on
work may be addressed on an individual level, rather than a
policy level or organisational level, to ensure that patients
receive support in managing their health in the context of
their work. In Denmark a multidisciplinary intervention in-
cluding case management has been evaluated in the re-
habilitation of employees sick-listed for 4–12 weeks due to
low back pain [25] and “Fit for Work” services, based on
case managed, multidisciplinary approaches providing
treatment, advice and guidance for people in the early
stages of sickness absence have been recommended in the
UK [6]. Case management can be defined as a “goal ori-
ented approach to keeping employees at work and facilitat-
ing an early return to work” [26]. Given that early
intervention is advocated, that musculoskeletal conditions
are a common cause of work absence and that many indi-
viduals seek their healthcare initially from their primary
care practitioner, testing a service located in primary care
that can address work issues early on in patients with mus-
culoskeletal conditions is appropriate. However, such a ser-
vice needs to have a broad enough scope to ensure
appropriate advice for the majority of patients whilst still
providing a tailored service, therefore the case management
approach is the most appropriate model.
Aim
This paper describes the rationale, design and methods for a
cluster randomised controlled trial and linked qualitative in-
terviews, to investigate the clinical and cost-effectiveness of
introducing a vocational advice service into general practice,
with the aim of providing a structured approach to man-
aging work related issues for primary care patients with
musculoskeletal pain who are absent from work or strug-
gling to remain in work.
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What is the effect of the addition of a vocational advice
service to best current care compared to best current care
alone, for adults with musculoskeletal conditions in pri-
mary care absent from or struggling to remain in work?
The secondary questions are:
1. Is the addition of a vocational advice service to best
current care compared to best current care alone for
adults with musculoskeletal conditions in primary care
absent from or struggling to remain in work cost
effective?
2. What are the experiences of patients, GPs/NPs and
vocational advisors of a primary care based
vocational advice service?
Ethical approval
Ethical approval was obtained from NRES Committee
West Midlands – Staffordshire in April 2012 (REC refer-
ence: 12/WM/0020).
Methods
Trial design
SWAP is a pragmatic cluster randomised controlled trial
with two parallel arms and incorporates economic evalu-
ation and linked qualitative interviews. The unit of ran-
domisation is the general practice with data collected
from individual participants.
Settings and clusters
This cluster trial will take place in six general practices
in the South Staffordshire area of the Staffordshire and
Stoke-on-Trent Partnership NHS Trust in the UK. In-
formed consent for practices to participate will be pro-
vided by the senior GP partner. Patients will follow the
care to which their practice is randomised with identical
participant information for both arms explaining that
their local musculoskeletal services are being evaluated
using patient self-complete questionnaires and medical
record review. A second information sheet was used to
inform participants about the interview study. Individual
patients will be able to opt-out of the questionnaire data
collection and the interview study.
Randomisation and allocation concealment
GP practices are the unit of randomisation. Practices re-
cruited to the cluster trial will be matched based on list size,
with matched practices subsequently randomly allocated to
the intervention or control arms. Allocation concealment
for participating GPs and vocational advisors is not possible
but individual participants will not know the allocation of
their practice. In this cluster RCT individual participants
will not know they are in a trial as the patient information
will not mention randomisation of practices and will simplyinform participants that local musculoskeletal services are
being evaluated. In addition, data entry staff who input data
from study questionnaires will be blind to allocation.
Analysis of the primary outcome will be carried out by two
statisticians (one of which will be blinded to treatment
arm). The results will be reviewed and agreed by both
statisticians, with one statistician remaining blind until
agreement on final estimates is reached.
Participant eligibility criteria
Adults aged 18 to 70 years consulting in primary care
with musculoskeletal pain will be eligible to take part if
they are:
 Currently employed (paid)
 Current sickness absence of less than 6 months
duration (either GP or self-certified absence) due to
musculoskeletal pain OR
 Patients considered by the GP (or a nurse
practitioner (NP)), during the consultation, to be
struggling with work due to musculoskeletal pain
Exclusion criteria are:
 Patients with symptoms indicative of possible serious
pathology, requiring urgent medical attention
 Patients unable to read and speak English
 Patients with serious mental health problems who
are vulnerable and for whom participation in the
study would be detrimental (at the GP’s discretion)
 Those who have long term work absence
(greater than 6 months)
 Pregnancy or those patients on maternity leave
Participant recruitment
Potential participants will be identified when they consult
their GP practice with musculoskeletal pain. When a Read
code for a musculoskeletal pain problem is entered in the
electronic medical record, a computer template will be ac-
tivated. The template will prompt the GP or NP to record
whether the patient is struggling to remain in work or ab-
sent from work. Patients who are present when the GP or
NP completes the computerised template and express an
interest in the research will be given a SWAP information
pack at the GP practice. The records of patients who are
not present with the GP or NP when the computer tem-
plate is completed, will be ‘tagged’ and downloaded on a
weekly basis. The local NIHR Clinical Research Network
Primary Care administrator will post an information pack
to these patients.
Electronic templates have been successfully implemented
in previous studies carried out by the Arthritis Research
UK Primary Care Centre at Keele University and are now
routinely used to identify participants for research studies
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include a letter of invitation, a participant information
sheet, consent form, self-completion questionnaire (base-
line data collection) and a pre-paid reply envelope. The
letter of invitation will invite potential participants to take
part by completing a consent form and returning the
baseline questionnaire. The information sheet will provide
further details about the trial. As participants will not be
individually consented to randomisation, participants in
both arms of the trial will be asked to give written consent
to take part in a study investigating work related musculo-
skeletal problems and local health services by completing
three questionnaires (at baseline, 4 months and 12 months)
and to allow the research team access to their medical re-
cords to identify GP certified Fit Notes in the 6 months
prior to consent and during the follow-up period, and to
review further health care utilisation for cost analysis. The
same procedure will be followed for both the intervention
and control practices. A flowchart illustrating the SWAP
trial is shown in Figure 1.
Description of intervention and control arms
All GPs and NPs working in both the intervention and
control practices will be invited to participate in an evi-
dence update session discussing best current care for theFigure 1 SWAP trial flowchart.management of musculoskeletal pain and work. This aims to
ensure that all patients receive the same level of best current
care, allowing the added benefit of the vocational advice ser-
vice to be assessed. The evidence update session will centre
on providing GPs and NPs with information to ensure that
the correct advice is provided to patients about working with
musculoskeletal pain. It will focus on the key messages that
a) work is usually good for people with musculoskeletal pain,
b) long periods of absence from work are harmful, c) muscu-
loskeletal pain can often be accommodated at work with ap-
propriate adjustments and support, if necessary d) planning
and supporting return to work are important parts of clinical
management. In addition to these key messages GPs and
NPs will be provided with advice about how to approach dis-
cussing difficult issues with patients such as negotiating ab-
sence or modified duties in the workplace.
Control practices
Control practices will provide best current care by GPs
and NPs in addition to all other usual care that patients
may require for their musculoskeletal pain.
Intervention practices
Intervention practices will also provide best current care
and all other care as usual. In addition to best current care
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practices. Patients who require help and support in
remaining at or returning to work may be referred to the
vocational advice service by their GP or NP, irrespective of
whether they also consent to participate in the research
evaluation. Patients who are referred to the vocational ad-
vice service will be contacted by a vocational advisor, seven
days after receipt of the referral who will help the patient to
identify and overcome obstacles to remaining at or return-
ing to work. The vocational advisor will wait for seven days
before contacting the patient to minimise the number of
participants who provide baseline data after having contact
with the vocational advisor. It is expected that obstacles to
return to work or remaining at work will fall into several
categories, and the Flags model of management [28] of the
health and work interface will be used to structure the vo-
cational advice service. The Flags model focuses on the
identification of obstacles to working with health condi-
tions, development of a plan to manage health and work,
taking action to address the issues each individual patient is
facing with respect to managing their musculoskeletal con-
dition in the workplace and re-evaluating the patient’s situ-
ation regularly until a sustained return to work is achieved
[28]. The model is a “light touch” approach based around
the principles of case management and stepped care, with
vocational advisors providing a goal oriented approach to
return to work or remaining in work and with patients be-
ing able to “step up” the support they receive when neces-
sary (Figure 2). Stepped care has been used successfully in
the management of mental health conditions and has
begun to be used successfully in pain management [29,30].
Patients will be eligible for continued vocational advice
until they have a sustained return to work, feel able to man-
age their health condition in the context of their work, or
until they have been absent from the workplace for a total
of six months, at which point they will be directed towards
other appropriate services.Figure 2 Model of stepped care provided by the vocational advisor (VAudit of intervention
The vocational advisors will complete case report forms
for each participant in the intervention arm, recording
basic demographic details, assessment findings and their
management plan, and the type and number of contacts
each participant has with the vocational advisor. An audit
on the completion of the case report forms against the vo-
cational advisor clinical case notes will assess whether pa-
tient demographics, contacts with the vocational advisor,
details of the assessment and management plan, and any
contact with other stakeholders (e.g. healthcare providers,
employers) are consistently and accurately recorded on
the case report forms.
Training and mentoring of vocational advisors
Four health care practitioners have been recruited to voca-
tional advisor posts for the trial. They attended a four day
training programme on managing work issues within pri-
mary care for patients with musculoskeletal conditions.
The training programme was based on stepped care and
case management principles. The vocational advisors also
attended a half day update just prior to the start of the vo-
cational advice service. Monthly mentoring meetings will
be scheduled throughout the study where the vocational
advisors have the opportunity to request further clarifica-
tion on any aspect of the teaching, and discuss individual
cases both with colleagues and the trainers (a consultant
physiotherapist and clinical psychologist who are experi-
enced in managing work related issues).
Sample size
In summary, 330 recruited participants (165 per arm) in
the SWAP trial will give 80% power to detect at least a
mean difference of 10 days (days off work between base-
line and 4 months) given an expected standard deviation
of 25 [31], and 5% two-tailed significance level. The pri-
mary analysis method is described below and does notA) in addressing return-to-work (RTW).
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rate ratio via a Poisson/negative binomial process). How-
ever, the above calculation holds when applying Normal
approximation to the binomial distribution as is generally
accepted when the combination of rate of occurrence and
sample size is sufficiently large (i.e. both np and n(1-p) ex-
ceed 5, where p in this case denotes the probability of tak-
ing time off work in any given day, and generally for any
Poisson process where the mean/rate is 10 or greater).
The model proposed for the analysis of the primary end-
point (number of days off work) is more suited for analys-
ing discrete data than general linear models which are
suited to continuous data.
The total sample size requirement for analysis of an un-
clustered unadjusted analysis based on detecting a mean
difference of 10 with 80% power and two-tailed 5% signifi-
cance level (assuming an SD of 25) is 200 individuals (100
per study arm). The above calculated total sample size re-
quirement of 330 participants for the SWAP trial takes
into account three levels of inflation (of the unadjusted
figure): (i) 20% (×1.2 magnification) through clustering of
data (at practitioner- level) based on an ICC for between-
practitioner effects of 0.05 [32] with anticipated average
cluster size of 5 per practitioner; (ii) 15% owing to vari-
ation in expected recruitment rates between GPs (based
on an expected coefficient of variation of 0.65) [33], and
(iii) 20% allowance for loss to follow-up at 4 months.
Participant (baseline) characteristics
Baseline data by trial arm will be summarised and pre-
sented. Baseline characteristics are to be compared be-
tween arms, and presented at the level of: (i) GP practice
clusters, and (ii) Patient characteristics.
Baseline data for GP practice characteristics include data
on the stratified variable for randomisation – i.e. practice
list size. Also, number of GP practitioners, median index
level of deprivation for the practice, mean age, and gender
(male/female) distribution of practice populations will
be described.
Also, comparison will be made between participants’
demographic, pain/disability and quality of life characteris-
tics. Mean (SD) and median (IQR) will be applied to nor-
mal and skewed numerical data respectively. Frequency
counts and percentages will be presented for nominal and
ordered data.
Balance of baseline characteristics is particularly import-
ant to establish for cluster trials given the (higher level) unit
of randomisation. A lack of balance is indicative of differen-
tial selection of patients to the trial across the treatment
arms (though appreciating that random difference will
occur due to randomisation and between-practice varia-
tions). A further limitation of the design is that ‘baseline’ as-
sessment occurs after initial GP or NP consultation and
therefore a difference in pain management responses mayoccur within that period – i.e. prior to baseline assessment
(so baseline, defined as the date the participant completes
the first questionnaire, in this context is not a true ‘baseline’
of where baseline is usually considered to be, prior to the
start of treatment). We may expect differences in treatment
(such as issuing of sickness certificates) to occur by this
baseline assessment and in particular there may already be
differences in approach that may influence the primary out-
come by the time of this first self-report baseline assess-
ment. Therefore, the primary analysis will not adjust for
baseline pain intensity (though this adjustment will be car-
ried out as a sensitivity analysis - see Analysis section for
further details). No formal statistical testing will be carried
out for differences in baseline characteristics as this is not
an ‘outcome’ for the trial.
Assessment of potential bias
Selection bias: Over the period of recruitment the number
of patients who consult with musculoskeletal pain and are
potentially eligible for the trial as coded by the GP or NP
on the computer prompt will be recorded in the interven-
tion and control practices. Any evidence of selection bias
in rate of uptake to the research and in baseline descrip-
tive statistics between the control and intervention prac-
tices will be explored. Demographic comparisons will be
drawn between trial participants, non-participants and
screened patients who do not take part.
Attrition bias: Differences between individuals that are
followed up and those who dropout is a concern, and may
result in between-arm bias in estimates particularly if drop-
out is unequal between the two trial arms and analysis fails
to take into account appropriate adjustment for missing
data. Thus, we will compare: (i) baseline characteristics of
those who are successfully followed up at 4 months against
those who dropout to assess whether those missing are
related to observed baseline factors, (ii) attrition rate be-
tween trial arms to assess whether there is a differential
dropout rate. Statistical adjustment will be carried out to
help address issues of imbalance in characteristics.
Outcome assessment
Primary outcome measure
The primary outcome measure is number of days off
work over 4 months from entry into the trial. This is
based on response to the following questions in the 4-
month self-report questionnaires: “Have you taken time
off work during the last 4 months (since your last ques-
tionnaire) because of your pain? If yes, please write in
the number of days, weeks or months you were off work
due to your pain in the last 4 months. (i.e. between
baseline and 4 month follow up assessments)”. Days off
work in this context jointly captures sick leave issued by
the GP and shorter length self-certified absences that
don’t require GP sign-off.
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Self-reported time off work (in binary form (yes/no)) will
be a secondary outcome. We will also undertake a separ-
ate analysis to compare the proportion of participants in
the two trial arms that are issued a GP sickness certificate
in the first 4 months (through review of medical records
for those who provide consent to medical record review).
Secondary evaluation will also look at self-reported time
off work and medical record review based sick certification
periods over 12 months follow-up.
Other secondary outcome measures include the Self-
efficacy to Return to Work Questionnaire [34], pain inten-
sity (0–10 rating scales), bothersomeness (1–5 rating scale),
global assessment of change and work performance (SPS6).
Table 1 summarises the outcome measures and their
respective time-points of data collection.
Analysis
Data will be analysed after the 4 month follow-up and the
12 month analysis, which will include Health EconomicTable 1 Outcome measures and timing of data collection
Measures Description
Primary outcome measures
Absence Work absence self-reported a
duration of absence, and stru
Secondary outcome measures
Pain intensity Three questions: 0–10 scales
‘usual’ and ‘least’ pain in last
Bothersomeness Single question: 1–5 point sc
Change Global Assessment of Change
Return to work self-efficacy Self-Efficacy Return to Work Q
Work performance Stanford presenteeism scale 6
question on performance at
Prognostic indicators or potential mediators
Demographics Gender, date of birth, socio-e
Employment Current work situation
Episode duration One question on duration of
plus one question on time si
Pain elsewhere Additional pain locations ind
Illness perceptions Musculoskeletal Illness Percepti
Revised (IPQ-R) Short-Form
Symptoms of anxiety and depression Hospital Anxiety and Depress
Pain self- efficacy Pain Self Efficacy Questionnai
Attitudes & beliefs (patients) re. work & health Newly developed questionna
Content of GP/NP consultation Questions regarding topics c
the GP/NP (including work)
Treatment satisfaction Question regarding satisfactio
Health economic measures
Health care utilisation Health Care Utilisation Questidata, will then follow. For the primary analysis (time (days)
off work in the first 4 months), the proposed analysis is by
hierarchical negative binomial regression adjusting for age,
gender, and GP practice size (at the GP-cluster level).
Multi-level robust Poisson and zero-inflated models taking
into account clustering of data and over-dispersion in the
spread of data will also be scrutinised (alongside the nega-
tive binomial model). The goodness of fit of each model
for observed versus predicted values will be scrutinised
(comparisons will be drawn through a likelihood-ratio test
and Akaike’s Information Criterion (AIC)). Mixed-models
(linear- or generalised- as appropriate to numerical and
categorical outcome data, respectively) will be fitted to es-
timate and test for between arm effects across primary
and secondary outcome measures – adjusting for baseline
covariates (as indicated above). An intention-to-treat ap-
proach analysing participants as per randomised allocation
will be followed.
A limitation to the design/methods of this trial is
the small number of GP practice clusters (i.e. units ofBaseline 4 months 12 months
nd GP certified including
ggling at work
✓ ✓ ✓
for ‘present’,
2 weeks
✓ ✓ ✓
ale ✓ ✓ ✓
– one question ✗ ✓ ✓
uestionnaire ✓ ✓ ✓
(SPS6), plus single
work
✓ ✓ ✓
conomic status (recent paid job title) ✓ ✗ ✓
✓ ✗ ✓
current episode,
nce pain-free month
✓ ✗ ✗
icated on a Body Manikin ✓ ✗ ✗
ons Questionnaire ✓ ✓ ✓
ion Questionnaire (HADs) ✓ ✓ ✓
re (PSEQ) ✓ ✓ ✓
ire ✓ ✓ ✓
overed by ✓ ✗ ✓
n with treatment ✗ ✓ ✗
ons ✗ ✗ ✓
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number of clusters for a valid methodological evaluation is
four per arm (our trial has three GP practices per arm)
[35]. Much of this concern centres on the assumptions for
the hierarchical model, and the fact that any cluster level
analysis (only) will fail to detect a statistically significant p-
value (at the level of the customary 5% two tail testing).
Hence, we propose to carry out the hierarchical model
with individual practitioners (GP/NPs as opposed to GP
practice) as the upper-level random factor. GP/NPs are
likely to be the main contributors to the variation in sick-
ness certification between GP practices and may therefore
be considered to be reasonable substitutes [36].
Descriptive statistics on numbers of participants and pro-
portion of participants who take time off work in each arm
will be reported for the primary outcome. The adjusted ef-
fect estimate (incidence rate ratio), 95% confidence interval
and p-value for the test of association for the primary meas-
ure will be presented. Similarly, mean scores (SDs) for nu-
merical outcomes and frequency counts and percentages
for categorical data will be presented for secondary out-
come measures – as appropriate to the scale of the data.
Mean differences and 95% CIs and odds ratios with 95%
CIs will be presented for all secondary outcomes – as ap-
propriate to the scale of the data.
Sensitivity analysis
The following sensitivity analyses are planned:
1. Evaluation of the primary outcome measure
(number of days off work) by robust Poisson and
zero-inflated models.
2. The main evaluations will utilise minimal covariate
adjustment (owing to the fact that differences may
already be inherent in baseline assessment due to
the time-scale of return of questionnaires following
the initial GP/NP consultation). However, we would
not anticipate any real difference in outcomes in
such a short time period particularly as the patients
in the intervention practices will not have been
contacted by a vocational advisor until at least 7 days
after receiving the baseline questionnaire. Greater
covariate adjustment is also relevant in that it helps
safeguard the analysis against major selection bias
and/ confounding bias. Thus, as a sensitivity analysis,
we will carry out statistical modelling that includes
additional baseline adjustment by further including
pain intensity, time off work at baseline (at the
individual level) as well as corresponding baseline
score (if applicable).
3. A second sensitivity analysis will be carried out at the
upper cluster level (individual practitioners) using
non-parametric sum rank test and permutations test.
Individual-level regression methods may not bereliable and the distributional assumptions difficult to
verify when the number of units of analysis are small –
in such circumstances, as is the case in this trial, it is
recommended to carry out a simple crude analysis that
is not dependent on distributional assumptions (in this
case a simple non parametric comparison since the
primary outcome of interest is likely to be highly
skewed) [37].
4. Per protocol evaluation (further sensitivity analysis
of the primary outcome): A per protocol evaluation
will be undertaken comparing the primary outcome
for those participants in the intervention practices
who engaged with any aspect of the vocational
advice service (at least one contact by telephone)
versus ‘comparable' participants in the control
practices. A complier average causal effect analysis
will be performed to provide an unbiased estimate of
‘per protocol’ effect by adjusting the per protocol
estimate (on the assumption that a similar level of
non-compliance would be expected for the control
arm).
Subgroup analyses: Evaluation of the primary outcome
measure will be carried out to examine whether time off
work/number of days absenteeism is different across dif-
ferent baseline subgroups by: return to work self-efficacy,
location of pain (spinal pain versus pain in other areas),
and duration of work absence. Statistical estimates will be
obtained through including interaction terms in the statis-
tical model of treatment effect.
Economic evaluation
The economic evaluation conducted alongside the SWAP
trial will determine the cost-effectiveness and return on
investment of the vocational advice service (cost-benefit
analysis) in comparison to best current care.
A cost-consequence analysis will initially be reported,
describing all the important results relating to costs and
consequences (across the full range of clinical outcomes).
Subsequently, two methods of economic evaluation will
be used. A cost-effectiveness analysis will be undertaken
from a healthcare perspective to determine the cost per
additional day of work absence avoided. A cost-benefit
analysis will also be undertaken from a broader societal
perspective to calculate the net societal benefit of the vo-
cational advice service, by subtracting the difference in dir-
ect health care costs (costs) between the groups from the
difference in indirect productivity costs (benefits) between
the trial arms.
Costs
Information on time off work will be collected from the
postal questionnaires completed by patients at 4 months
and 12 months. Health care resource use will be collected
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clude primary and secondary care contacts, investigations,
medication and contacts with other health care profes-
sionals such as physiotherapists and occupational thera-
pists (both through the NHS and private). Data on
musculoskeletal pain related time off work and health care
resource use will also be available from the medical record
review. Questions on patients’ personal expenditure will
concentrate on private health care use and over-the-
counter treatments. Questions on time off work and occu-
pation will provide information required to calculate the
indirect (productivity) costs (benefits). In order to obtain
the cost of the vocational advice service, information on
the type and number of contacts with the vocational ad-
visor (telephone calls or visits) will be obtained and unit
costs applied to calculate overall cost of the intervention.
Resource use will be multiplied by unit costs obtained
from standard (national) sources and health care pro-
viders [38-40]. Due to the lack of nationally representa-
tive unit cost estimates for private health care, this care
will be costed as the NHS equivalent. Patient reported
costs for over-the-counter treatments will be used.
Health economic outcomes
The outcome measure for the cost-effectiveness analysis
is self-reported number of days absent from work. In the
cost-benefit analysis, benefits will be estimated from the
productivity losses. These will be calculated using data
collected on employment status at every time point and
number of days off work due to their musculoskeletal
pain problem. Information on occupation, further details
of typical work activities and the nature of their employ-
ment (full time or part time) will be sought in follow-up
questionnaires. The average wage for each respondent
will be identified using UK Standard Occupational Clas-
sification coding and annual earnings data for each job
type [41,42]. The analysis will use the human capital ap-
proach, and the self-reported days of absence will be
multiplied by the respondent-specific wage rate. The hu-
man capital approach assumes that the value of lost
work is equal to the amount of resources an individual
would have been paid to do that work, and values prod-
uctivity losses as a result of morbidity (or mortality) by
measuring time lost from work and multiplying this with
the gross wage of the person.
Cost-consequence, cost-effectiveness and
cost-benefit analysis
The health economic analysis will estimate the incre-
mental cost-effectiveness and the cost-benefit of the
intervention in comparison with best current care. Costs
for the trial arms will be presented for each broad cost
category (health care costs, patient-incurred costs, prod-
uctivity costs) and disaggregated within each of thesecost categories. An incremental cost-effectiveness analysis
will be conducted from a healthcare perspective using
information on time off work to calculate the cost per
additional day of work absence avoided. A cost-benefit
analysis from a broader societal perspective will calculate
the net societal benefit of the intervention in monetary
terms, by subtracting the difference in costs from the dif-
ference in benefits (productivity losses). Subsequently, a
return on investment will be calculated by dividing the net
benefits of the vocational advice service (gain minus cost)
by the net costs of the intervention. The base-case ana-
lyses will use self-reported patient information on health
care utilisation over a 12 month period.
The data for costs is likely to have a skewed distribution
therefore a non-parametric comparison of means (e.g.
bootstrapping) will be undertaken to estimate confidence
intervals around costs. Mean substitution techniques (for
individual-item missing resource use data) and multiple
imputation techniques (resource use data) will be carried
out to ensure that all trial participants are included in the
final analysis. Clustering of data by GP/NP will be taken
into account through a multi-level approach, in line with
the main statistical analysis. Adjustment for baseline co-
variates will focus on the same variables as outlined for
the primary clinical evaluation.
The robustness of the base-case results will be explored
using sensitivity analysis. This will explore uncertainties in
the trial based data itself and the methods employed to col-
lect and analyse the data. An available case analysis will be
conducted as an alternative to using a multiple-imputed
data set. A further sensitivity analysis will be undertaken
using health care resource use data solely obtained from
the medical record review. Uncertainty will be explored
through the use of cost-effectiveness acceptability curves
(CEACs); these plot the probability that the addition of a
vocational advice service is cost-effective against threshold
values for cost-effectiveness.
Qualitative research
Qualitative methods
In linked qualitative interviews we will explore experiences
of the vocational advice service from the perspectives of
GPs and NPs in the intervention practices who can refer
patients to the service, patients who access the service
with work related problems and vocational advisors who
are delivering the service. GPs and NPs (up to n = 15) will
be interviewed both prior to the start of the new service
and 12 months later. Patients (n = 20) who have consented
to the research evaluation will be opportunistically invited
for interview following discharge from the care of the vo-
cational advisors. Vocational advisors (n = 4) will be inter-
viewed four times, prior to the start of the new service and
at 1, 6 and 12 months after the vocational advice service
commences. These longitudinal interviews will explore
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viding the vocational advice service evolves over time.
Qualitative analysis
Interviews with GPs/NPs, patients and vocational advi-
sors will initially be coded in N-vivo 9 and subsequently
analysed in search of common themes and differences,
using the constant comparative framework, based on the
broad principles of grounded theory [43]. Although each
set of interviews will be coded separately (using separate
coding frameworks), each dataset will subsequently be
analysed as a whole in search of similarities and differ-
ences across GPs/NPs, patients and vocational advisors.
Samples of early interviews will be independently coded
by members of the multidisciplinary research team, coding
frameworks agreed and coded data analysed in search of
themes at multidisciplinary research analysis meetings.
The themes will be analysed through in-depth discussion
to examine plausibility and validity to develop a robust
thematic framework (or conceptual model); specifically
patients’, vocational advisors’ and GPs/NPs’ perceptions of
the acceptability, benefits and limitations of the vocational
advice service. The constant comparative method will pro-
vide a means of identifying similarities and differences in
the qualitative data, whilst the longitudinal dimension of
the qualitative interviews with VAs (baseline, 1 month,
6 months and 12 months) and GPs/NPs (baseline and
12 months) will identify changes over time in attitudes
and experiences towards the acceptability and added value
(or otherwise) of the vocational advice service.
Trial timeline Trial recruitment commenced in July
2012. We aim to recruit 330 participants into the trial over
an 18 month period from 6 general practices. Follow-up is
targeted for completion by January 2015 and analysis
will follow.
Discussion
The SWAP trial is investigating the clinical and cost-
effectiveness of the addition of a vocational advice service
to best current primary care to provide a structured ap-
proach to managing work related issues in primary care
patients with musculoskeletal pain who are absent from
work or struggling to remain in work. Given that early
intervention is advocated, that musculoskeletal conditions
are a common cause of work absence and that the major-
ity of individuals in the UK seek their healthcare initially
from their GP, we have developed and are testing a service
located in primary care to address the issues of health and
work early on in patients with musculoskeletal conditions.
This is the first such trial in the UK. The results will pro-
vide evidence to inform primary care practice and may
guide the development of services to provide support for
musculoskeletal pain patients with work-related issues.The main strength is the cluster randomised controlled
trial design. The primary outcome is self-reported number
of days off work over 4 months. A range of secondary out-
comes will also be assessed and qualitative interviews will
explore the value of a vocational advice service to GPs and
NPs, patients and vocational advisors.
Abbreviations
GP: General practitioner; ICC: Intracluster correlation coefficient;
IQR: Interquartile range; NIHR: National Institute for Health Research;
NHS: National Health Service; NP: Nurse practitioner; RCT: Randomised
controlled trial; RTW: Return to work; SD: Standard deviation; SME: Small and
medium enterprise; SWAP: Study of work and pain; UK: United Kingdom;
VA: Vocational advisor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NF, EH, CM, DvdW, ML and GW-J conceptualised and designed the study
and secured funding. AB, GW-J, ML, SJ and NF wrote the full protocol. AB
wrote the first draft of this manuscript. SL is the study coordinator and
contributed to the operational aspects of the trial in the protocol. CM offered
specific expertise in occupational health, contributed to the initial funding
proposal, and training/mentoring the VAs in secondary prevention. GS
conceptualised, designed and delivered the vocational advisors’ intervention,
training and mentoring. KB contributed to the conceptual development of
the best current care and vocational advice interventions and contributed
these to the protocol. ML is the study statistician, advised on the sample size,
advised on the data collection and formulated the analysis plan. SJ advised
on the data collection and formulated the analysis plan for the economic
evaluation. TS conceptualised and designed the qualitative study and
contributed to the protocol. All authors contributed to revisions of this
manuscript, have read and approved the final manuscript and take public
responsibility for its content.
Acknowledgements
We thank the participating patients, GPs, NPs and practice managers. We
thank the SWAP trial independent steering committee for their advice and
support. We acknowledge the PCRN (for GP research facilitators, Clinical
Support Officers and administrators), the administration team, the research
nurse team, our PPI research user group members. We are grateful to all the
members of the wider SWAP trial team including: Majid Artus (clinical liaison
and support to GPs), Helen Duffy (consortium manager) , Alicia Bratt
(administration), Simon Wathall (Health Informatics) Jackie Gray and Rhian
Hughes (research governance and management), Julie Young (lead research
nurse), Ruth Beardmore (research management) and the vocational advisors
(Phaldie Gool, Tina Hadley-Barrows, June Handy, Rachel Jackson). We are
grateful to Staffordshire and Stoke-on-Trent Partnership Trust for clinical
governance of the vocational advice service.
Funding
This paper presents independent research funded by the National Institute
for Health Research (NIHR), under its Programme Grants for Applied Research
funding scheme: “Optimal management of spinal pain and sciatica in
primary care” (NIHR-RP-PG-0707-10131). NF and AB are funded by an NIHR
Research Professorship for NE Foster (NIHR-RP-011-015). GW-J is funded by
an NIHR Research Post-doctoral Fellowship (PDF-2009-02-54). The views
expressed are those of the authors and not necessarily those of the NHS, the
NIHR or the Department of Health.
Author details
1Research Institute for Primary Care & Health Sciences, Keele University,
Keele, Staffordshire ST5 5BG, UK. 2Institute for Research in Citizenship and
Applied Human Sciences, University of Huddersfield, Huddersfield, UK.
3School of Health and Population Sciences, University of Birmingham,
Birmingham, UK.
Received: 16 June 2014 Accepted: 23 June 2014
Published: 10 July 2014
Bishop et al. BMC Musculoskeletal Disorders 2014, 15:232 Page 11 of 11
http://www.biomedcentral.com/1471-2474/15/232References
1. CBI Fit for Purpose: Absence and Workplace Health Survey 2013; http://www.cbi.
org.uk/media/2150120/cbi-pfizer_absence___workplace_health_2013.pdf.
2. Department of Health, Health and Safety Executive, Department for Work and
Pensions: Health, Work and Well-being - Caring for Our Future. London; 2005.
3. Health Work and Wellbeing. Improving health and work: changing lives. 2013.
https://www.gov.uk/government/uploads/system/uploads/attachment_data/
file/210858/hwwb-improving-health-and-work-changing-lives.pdf.
4. Department for Business Enterprise and Regulatory Reform: Small and
Medium-sized Enterprise (SME) Statistics for the UK and Regions 2007
URN 08/92; 2008.
5. Health and Safety Executive: Survey of Use of Occupational Health Support.
Norwich: Her Majestys Stationary Office; 2002a.
6. Black C: Working for a Healthier Tomorrow. London: The Stationary Office; 2008.
7. Buchbinder R, Jolley D, Wyatt M: Population based intervention to change
back pain beliefs and disability: three part evaluation. Br Med J 2001,
322(7301):1516–1520.
8. McGuirk B, Bogduk N: Evidence-based care for low back pain in workers
eligible for compensation. Occup Med 2007, 57(1):36–42.
9. Waddell G, Burton AK: Is Work Good for Your Health and Wellbeing? London:
TSO; 2006.
10. Waddell G, Feder G, Lewis M: Systematic reviews of bed rest and advice
to stay active for acute low back pain. Br J Gen Pract 1997, 47:647–652.
11. Waddell G, Burton AK, Kendall N: Vocational Rehabilitation: What Works, for
Whom, and When? London: TSO; 2008.
12. Health and Safety Executive: Working Together to Prevent Sickness Absence
Becoming Job Loss; 2002b. http:www.hse.gov.uk/pubns/web02.pdf.
13. Cabinet Office: Managing Sickness Absence in the Public Sector: A joint review
by the Ministerial Task Force for Health, Safety and Productivity and the
Cabinet Office. London: TSO; 2004.
14. Waddell G, Burton AK: Occupational Health Guidelines For The Management
Of Low Back Pain At Work - Evidence Review. London: Faculty of
Occupational Medicine; 2000.
15. Waddell G, Burton AK: Work and Health: Changing How We Think About
Common Health Problems. London: TSO; 2006.
16. Waddell G, Burton AK: Advising Patients About Work. London: TSO; 2007.
17. Waddell G, Burton AK: Health and Work. London: TSO; 2007.
18. Hann M, Sibbald B: General Practitioners’ Attitudes Towards Patients’ Health
and Work. London: Department for Work and Pensions; 2011.
19. Hiscock J, Ritchie J: The Role of GPs in Sickness Certification. Leeds: Her
Majesty’s Stationary Office; 2001.
20. Mowlam A, Lewis J: Exploring How General Practitioners Work with People on
Sick Leave. London: Department for Work and Pensions; 2005.
21. Nice K, Irvine A, Sainsbury R: The Impact of Pathways to Work. London:
Department for Work and Pensions; 2008.
22. Nice K, Thornton P: Job Retention and Rehabilitation Pilot: Employers
Management of Sickness Absence. London: Department for Work and
Pensions; 2004.
23. Van Tulder M, Becker A, Bekkering T, Breen A, del Real MT, Hutchinson A,
Koes B, Lærum E, Malmivara A: Chapter 3. European guidelines for the
management of acute nonspecific low back pain in primary care.
Eur Spine J 2006, 15(Suppl 2):S169–91.
24. Franche RL, Cullen K, Clarke J, Irvin E, Sinclair S, Frank J: Workplace-based
return-to-work interventions: a systematic review of the quantitative
literature. J Occup Rehabil 2005, 15:607–631.
25. Hanson MA, Burton AK, Kendall NAS, Lancaster RJ, Pilkington A: The Costs
and Benefits of Active Case Management and Rehabilitation for
Musculoskeletal Disorders; 2006. Health and Safety Executive: http://www.hse.
gov.uk/research/rrpdf/rr493.pdf.
26. Stapelfeldt CM, Christiansen DH, Nielsen CV, Petersen KD, Jensen C:
Subgroup analyses on return to work in sick-listed employees with low back
pain in a randomised trial comparing brief and multidisciplinary intervention.
BMC Muscuskel Disord 2011, 12:112. doi:10.1186/1471-2474-12-112.
27. Hill JC, Dunn KM, Lewis M, Mullis R, Main CJ, Foster NE, Hay EM: A primary
care back pain screening tool: Identifying patient subgroups for initial
treatment. Arthritis Care Res 2008, 59(5):632–641.
28. Kendall NAS, Burton AK, Main CJ, Watson PJ, on behalf of the Flags Think-Tank:
Tackling Musculoskeletal Problems: a Guide for the Clinic and Workplace – Identifying
Obstacles Using the Psychosocial Flags Framework. London: TSO; 2009.29. National Institute for Health and Clinical Excellence: Depression: Treatment
and Management of Depression in Adults, Including Adults with a Chronic
Physical Health Problem; 2009.
30. Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, Tu W:
Optimized antidepressant therapy and pain self-management in primary
care patients with depression and musculoskeletal pain: a randomized
controlled trial. J Am Med Assoc 2009, 301:2099–2110.
31. Weidenhammer W, Linde K, Streng A, Hoppe A, Melchart D: Acupuncture
for chronic low back pain in routine care. Clin J Pain 2007, 23:128–135.
32. Lewis M, Morley S, van der Windt DA, Hay E, Jellema P, Dziedzic K, Main CJ:
Measuring practitioner/therapist effects in randomised trials of low back
pain and neck pain interventions in primary care settings. Eur J Pain
2010, 14:1033–1039.
33. Eldridge SM, Deborah D, Kerry S: Sample size for cluster randomized trials:
effect of coefficient of variation of cluster size and analysis method. Int J
Epidemiol 2006, 35:1292–1300.
34. Shaw WS, Endresen Reme S, Linton SJ, Huang Y-H, Pransky G: Development of
the return-to-work self-efficacy (RTWSE-19) questionnaire – psychometric
properties and predictive validity. Scand J Work Environ Health 2011,
37:109–119.
35. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ:
Patterns of intra-cluster correlation from primary care research to inform
study design and analysis. J Clin Epidemiol 2004, 57(8):785–794.
36. Watson PJ, Bowey J, Purcell-Jones G, Gales T: General practitioner sickness
absence certification for low back pain is not directly associated with
beliefs about back pain. Eur J Pain 2008, 12(3):314–320. Epub 2007 Jul 30.
37. Hayes RJ, Moulton LH: Cluster Randomised Trials. London: Chapman & Hall/
CRC Press; 2009.
38. Curtis L: Unit Costs of Health and Social Care 2013. Personal Social Services
Research Unit; http://www.pssru.ac.uk/project-pages/unit-costs/2013/.
39. Department of Health: NHS Reference Costs 2012/2013; https://www.gov.uk/
government/publications/nhs-reference-costs-2012-to-2013.
40. British National Formulary: 66th edition. London: BMJ Books; 2013.
41. Office for National Statistics: Standard Occupational Classification; 2010.
http:www.ons.co.uk.
42. Office for National Statistics: Annual Survey of Hours and Earnings; 2013.
Available at: http://www.ons.gov.uk.
43. Strauss A, Corbin J: The Basics of Qualitative Research: Techniques and
Procedures for Developing Grounded Theory. London: Sage; 1990.
doi:10.1186/1471-2474-15-232
Cite this article as: Bishop et al.: Rationale, design and methods of the
Study of Work and Pain (SWAP): a cluster randomised controlled trial
testing the addition of a vocational advice service to best current primary
care for patients with musculoskeletal pain (ISRCTN 52269669). BMC
Musculoskeletal Disorders 2014 15:232.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
